Follow
Ryan Zurakowski
Ryan Zurakowski
Associate Professor of Biomedical Engineering, University of Delaware
Verified email at udel.edu - Homepage
Title
Cited by
Cited by
Year
HIV-1 persistence in CD4+ T cells with stem cell–like properties
MJ Buzon, H Sun, C Li, A Shaw, K Seiss, Z Ouyang, E Martin-Gayo, ...
Nature Medicine 20, 139-142, 2014
4152014
Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells
MJ Buzon, E Martin-Gayo, F Pereyra, Z Ouyang, H Sun, JZ Li, M Piovoso, ...
Journal of virology 88 (17), 10056-10065, 2014
2702014
A model predictive control based scheduling method for HIV therapy
R Zurakowski, AR Teel
Journal of Theoretical Biology 238 (2), 368-382, 2006
1942006
The Tobit Kalman Filter: An Estimator for Censored Measurements
B Allik, C Miller, MJ Piovoso, R Zurakowski
IEEE Transactions on Control Systems Technology, 10.1109/TCST.2015.2432155, 2015
792015
HIV Model Parameter Estimates from Interruption Trial Data including Drug Efficacy and Reservoir Dynamics
R Luo, MJ Piovoso, J Martinez-Picado, R Zurakowski
PLoS One 7 (7), e40198, 2012
782012
Enhancing immune response to HIV infection using MPC-based treatment scheduling
R Zurakowski, AR Teel
Proceedings of the American Control Conference 2, 1182-1187, 2003
542003
Nonlinear estimators for censored data: a comparison of the EKF, the UKF and the Tobit Kalman filter
B Allik, C Miller, MJ Piovoso, R Zurakowski
2015 American Control Conference (ACC), 5146-5151, 2015
452015
Modelling HIV-1 2-LTR dynamics following raltegravir intensification
R Luo, EF Cardozo, MJ Piovoso, H Wu, MJ Buzon, J Martinez-Picado, ...
J. R. Soc. Interface 10 (84), 20130186, 2013
412013
Model-driven approaches for in vitro combination therapy using ONYX-015 replicating oncolytic adenovirus
R Zurakowski, D Wodarz
Journal of theoretical biology 245 (1), 1-8, 2007
362007
Estimation of Saturated Data Using the Tobit Kalman Filter
B Allik, C Miller, MJ Piovoso, R Zurakowski
American Control Conference (ACC), 2014, 4151-4156, 2014
342014
Optimal antiviral switching to minimize resistance risk in HIV therapy
R Luo, MJ Piovoso, J Martinez-Picado, R Zurakowski
PloS one 6 (11), e27047, 2011
342011
Nonlinear observer output-feedback MPC treatment scheduling for HIV
R Zurakowski
Biomedical engineering online 10 (1), 40, 2011
31*2011
Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence
J Martinez-Picado, R Zurakowski, MJ Buzón, M Stevenson
Retrovirology 15 (1), 1-11, 2018
282018
Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification
EF Cardozo, R Luo, MJ Piovoso, R Zurakowski
Journal of theoretical biology 345, 61-69, 2014
28*2014
Persistence of an intact HIV reservoir in phenotypically naive T cells
EV Rullo, MR Pinzone, LM Cannon, S Weissman, M Ceccarelli, ...
JCI insight 5 (20), 2020
262020
Treatment scheduling for HIV using robust nonlinear model predictive control
R Zurakowski, MJ Messina, SE Tuna, AR Teel
Australian Journal of Electrical & Electronics Engineering 2 (1), 49, 2005
26*2005
Ballistic Roll Estimation Using EKF Frequency Tracking and Adaptive Noise Cancellation
B Allik, M Ilg, R Zurakowski
IEEE Transactions on Aerospace and Electronic Systems 49 (4), 2546-2553, 2013
252013
Controlling the evolution of resistance
R Luo, LM Cannon, J Hernandez, MJ Piovoso, R Zurakowski
Journal of Process Control 21 (3), 367-378, 2011
222011
Utilizing alternate target cells in treating HIV infection through scheduled treatment
R Zurakowski, AR Teel, D Wodarz
American Control Conference (ACC), 2004, 1, 946-951, 2004
222004
Modeling Uncertainty in Single-Copy Assays for HIV.
R Luo, MJ Piovoso, R Zurakowski
J. Clin. Microbiol. 50 (10), 3382-3383, 2012
192012
The system can't perform the operation now. Try again later.
Articles 1–20